O'Brien M F, Johnston N, Stafford G, Gardner M, Pohlner P, McGiffin D, Brosnan A, Duffy P
Department of Cardiac Surgery & Pathology, Prince Charles Hospital, Brisbane, Australia.
J Card Surg. 1988 Sep;3(3 Suppl):279-87. doi: 10.1111/jocs.1988.3.3s.279.
From June 1975 to December 1987, 231 patients underwent aortic valve replacement with a viable cryopreserved allograft aortic valve. Throughout this era, a uniform procurement and preservation was used to maintain leaflet fibroblast viability. The allograft valve was obtained from coroner's autopsies within 24 hours of death, and more recently from organ donors, incubated for 24 hours in low dose antibiotic solution followed immediately by cryopreservation (mean time interval 39 hours after donor death). Viability was ensured by monitoring glucose utilization of the aortic and pulmonary valves and by demonstrating fibroblast growth in tissue cultured from the pulmonary valve. A uniform protocol for valve preparation was used during the entire experience. Nine allograft aortic valves have been obtained by eight reoperations (two were for leaflet degeneration) and one autopsy. The time intervals from implantation to explantation were 2 months, 10 months, 20 months, 22 months, 2.2 years, 5 years, 8.3 years, 9.2 years, and 10.8 years. Histologic examination of the leaflet tissue disclosed a variable degree of cellularity, ranging from a highly cellular matrix (9.2 years) to minimal cellularity (20 months). Within the same valve (10 months), one leaflet was completely acellular with a moderate degree of cellularity in the other two leaflets. The competent valve recovered at autopsy (8.2 years) was essentially acellular. Fibroblasts could consistently be cultured from leaflets in which viable cells were seen histologically. Chromosomal analysis of cultured cells from a valve leaflet (9.2 years) that was implanted with a donor and recipient sex mismatch demonstrated persistence of donor cells.(ABSTRACT TRUNCATED AT 250 WORDS)
1975年6月至1987年12月,231例患者接受了带活性冷冻保存同种异体主动脉瓣的主动脉瓣置换术。在整个这一时期,采用统一的获取和保存方法来维持瓣叶成纤维细胞的活性。同种异体瓣膜在死亡后24小时内从验尸官尸检中获取,最近则从器官捐献者处获取,在低剂量抗生素溶液中孵育24小时,随后立即进行冷冻保存(捐献者死亡后的平均时间间隔为39小时)。通过监测主动脉瓣和肺动脉瓣的葡萄糖利用情况以及通过证实从肺动脉瓣培养的组织中成纤维细胞的生长来确保活性。在整个经验过程中使用了统一的瓣膜制备方案。通过8次再次手术(2次是因瓣叶退变)和1次尸检获得了9个同种异体主动脉瓣。从植入到取出的时间间隔分别为2个月、10个月、20个月、22个月、2.2年、5年、8.3年、9.2年和10.8年。瓣叶组织的组织学检查显示细胞密度程度各异,从高细胞密度基质(9.2年)到最低细胞密度(20个月)。在同一个瓣膜(10个月)内,一个瓣叶完全无细胞,另外两个瓣叶细胞密度中等。尸检时回收的功能正常的瓣膜(8.2年)基本无细胞。从组织学上可见有活细胞的瓣叶中始终能够培养出成纤维细胞。对一个植入时供体和受体性别不匹配的瓣膜瓣叶(9.2年)培养的细胞进行染色体分析显示供体细胞持续存在。(摘要截短至250词)